Publications
-
Use of neurodevelopmental delay in pediatric solid organ transplant listing decisions: inconsistencies in standards across major pediatric transplant centers.
Richards CT,
Crawley LM, Magnus D.
Pediatr Transplant.
2009;
13
(7):
843-50
-
Direct-to-consumer genetic tests: beyond medical regulation?
Magnus D,
Cho MK, Cook-Deegan R.
Genome Med.
2009;
1
(2):
17
-
Research ethics consultation: the Stanford experience.
Cho MK,
Tobin SL, Greely HT, McCormick J, Boyce A, Magnus D.
IRB.
2008 Nov-Dec;
30
(6):
1-6
-
Response to Open Peer Commentaries on "Strangers at the Beachside: Research Ethics Consultation"
Cho MK,
Tobin SL, Greely HT, McCormick J, Boyce A, Magnus D.
Am J Bioeth.
2008;
8
(3):
4-6
-
Strangers at the benchside: research ethics consultation.
Cho MK,
Tobin SL, Greely HT, McCormick J, Boyce A, Magnus D.
Am J Bioeth.
2008;
8
(3):
4-13
-
The green revolution in bioethics.
Magnus D,
Am J Bioeth.
2008;
8
(8):
1-2
-
Blood, sweat and tears.
Magnus D,
Am J Bioeth.
2006 May-Jun;
6
(3):
1-2
-
A commentary on oocyte donation for stem cell research in South Korea.
Magnus D,
Cho MK.
Am J Bioeth.
2006 Jan-Feb;
6
(1):
W23-4
-
Stem cell research: the California experience.
Magnus D,
Hastings Cent Rep.
2006 Jan-Feb;
36
(1):
26-8
-
Research conduct. Lessons of the stem cell scandal.
Cho MK,
McGee G, Magnus D.
Science.
2006;
311
(5761):
614-5
-
Ethics. Issues in oocyte donation for stem cell research.
Magnus D,
Cho MK.
Science.
2005;
308
(5729):
1747-8
-
Stem cell research should be more than a promise.
Magnus D,
Hastings Cent Rep.
2004 Sep-Oct;
34
(5):
35-6
-
Politics and peer review.
Magnus D,
Am J Bioeth.
2004;
4
(1):
7-8
-
New life forms: new threats, new possibilities.
Caplan AL,
Magnus D.
Hastings Cent Rep.
2003 Nov-Dec;
33
(6):
7
-
Protecting subjects' interests in genetics research.
Merz JF,
Magnus D, Cho MK, Caplan AL.
Am J Hum Genet.
2002;
70
(4):
965-71
-
The meaning of graduate education for bioethics.
Magnus D,
Am J Bioeth.
2002;
2
(4):
10-2
-
In focus. Core faculty and their publications at bioethics centers in the United States.
Magnus D,
Miller V, Carroll K.
Am J Bioeth.
2002;
2
(4):
W20
-
Evaluating graduate programs in bioethics: what measures should we use?
McGee G,
Magnus D, Carroll K.
Am J Bioeth.
2002;
2
(4):
1-2
-
Is there a bioethicist in your company? Should there be?
Magnus D,
Drug Discov Today.
2002;
7
(7):
385-7
-
Who Owns Life?
David Magnus,
Ed. with Art Caplan and Glenn McGee.
Who Owns Life?.
2002
-
Bioethics programs evolve as they grow.
Magnus D,
Nat Biotechnol.
2001;
19
(10):
991-2
-
NAS cloning hearing disappoints participants.
Magnus D,
Caplan A.
Science.
2001;
294
(5547):
1651
-
Family problems.
Magnus D,
Dagostino L.
Am J Bioeth.
2001;
1
(3):
1
-
Reason and repugnance.
Callahan D,
Magnus D.
Med Ethics (Burlingt Mass).
2001:
6-7
-
Ethical issues: from genome to therapy.
Magnus D,
Novartis Found Symp.
2000:
229
122-5; discussion 125-30
-
Policy forum: genetics. Ethical considerations in synthesizing a minimal genome.
Cho MK,
Magnus D, Caplan AL, McGee D.
Science.
1999;
286
(5447):
2087, 2089-90
-
What is immoral about eugenics?
Caplan AL,
McGee G, Magnus D.
BMJ.
1999;
319
(7220):
1284-5
-
Disease gene patenting: the clinician's dilemma.
Magnus D,
Camb Q Healthc Ethics.
1998;
7
(4):
433-5
Help